The newly published results of two small clinical trials suggest that two novel antibiotics could provide safer alternatives ...

In 2023, tuberculosis claimed approximately 1·3 million lives,1 providing a stark reminder of the persistent inequities and ...

DOH Usec. Abdullah B. Dumama Jr, Cluster Lead of the National UHC Health Services Cluster (UHC-HSC) and concurrent head of ...

Current treatment for bedaquiline-resistant tuberculosis is linked with poor microbiological responses, unfavorable clinical ...

Ethiopia commemorated World TB Day on 23 March 2025 in Arba Minch City under the global theme:“Yes! We Can End TB! Commit, Invest, Deliver!” The event featured a range of activities, including ...

The drugs, sutezolid and delpazolid, have demonstrated strong antimicrobial activity and a notably better safety profile ...

Physicians who champion immunization sustain herd immunity, reducing the incidence of severe diseases, hospitalizations, and ...

Tuberculosis remains the world's leading infectious killer, resulting in more than 1·25 million deaths in 2023 alone.1 During ...

Detailed analysis of TB-related deaths in India, highlighting the need for audits to meet TB elimination goals.

Tamil Nadu integrates predictive model to reduce TB deaths, prioritizing severely ill patients for prompt hospital admission.

The drugs, sutezolid and delpazolid, have demonstrated strong antimicrobial activity and a notably better safety profile compared to linezolid, with potential to replace this current cornerstone in ...

Tuberculosis remains a major health challenge in South Africa, but professional nurse Nhlanhla Mofokeng is determined to change that through education, compassion, and community support.